Fumihito Hirai

23PUBLICATIONS
108CO-AUTHORS
Public health nutritionImmunogenetics (incl. genetic immunology)Pacific Peoples diet and nutritionStructural properties of condensed matterApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 01, 2026
Nutrition management and self-perceived relapse triggers in patients with inflammatory bowel disease: results from the 3R web-based survey.

|Mar 30, 2026
Impact of mirikizumab on patient-reported outcomes and quality of life in patients with Crohn's disease: results from the phase 2 SERENITY study.

Vipul Jairath, Theresa Hunter Gibble, Laurent Peyrin-Biroulet

|Aug 25, 2025
Prospective Questionnaire Survey on Adherence to Oral 5-Aminosalicylic Acid in Patients With Ulcerative Colitis.

Tsuyoshi Beppu, Fumihito Hirai, Kensei Ohtsu

|Jun 30, 2025
Fecal Calprotectin is a Useful Biomarker for Defining Small Bowel Endoscopic Remission in Crohn's Disease Without Active Colonic Lesions: A Prospective Multicenter Study from the IBD-Quality Team.

Teruyuki Takeda, Nobuaki Nishimata, Shin Fujioka

|Jun 27, 2025
Guselkumab in East Asians With Moderate-to-Severe Ulcerative Colitis: Subgroup Analysis of the QUASAR Induction and Maintenance Studies.

Baili Chen, Byong Duk Ye, Qian Cao

|May 31, 2025
Comparison Analysis of Lenvatinib Plus Transcatheter Arterial Chemoembolization Versus Atezolizumab Plus Bevacizumab as First-Line Therapy for Intermediate-Stage Hepatocellular Carcinoma Beyond the Up-to-Seven Criteria.

Takashi Niizeki, Seiichi Mawatari, Michihiko Shibata

Pageof 4

Frequent Collaborators

5 joint publications

Kenji Watanabe

4 joint publications

Sakiko Hiraoka

3 joint publications

Kazuhide Takata

3 joint publications

Motoi Uchino